Catalyst Pharmaceuticals, Inc.
Florida
United States
374 articles about Catalyst Pharmaceuticals, Inc.
-
Catalyst Pharmaceutical Partners to Transfer To NASDAQ Capital Market
9/3/2009
-
Catalyst Pharmaceutical Partners Licenses Exclusive Rights to New Class of GABA Aminotransferase Inhibitors From Northwestern University
8/31/2009
-
Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
8/7/2009
-
Catalyst Pharmaceutical Partners Cocaine Addiction Drug Fails
5/29/2009
-
Catalyst Pharmaceutical Partners Receives NASDAQ Deficiency Notice
5/26/2009
-
Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results
5/14/2009
-
Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results
3/27/2009
-
Catalyst Pharmaceutical Partners Scales Back Clinical Trial to Conserve Cash; Company to Focus Resources on its Lead Indication for CPP-109; Cocaine Addiction
3/3/2009
-
Catalyst Pharmaceutical Partners Reports Third Quarter 2008 Financial Results
11/14/2008
-
Catalyst Pharmaceutical Partners Announces a $4.5 Million Registered Direct Common Stock Offering
9/12/2008
-
Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
8/21/2008
-
Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
8/15/2008
-
Catalyst Pharmaceutical Partners Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
6/30/2008
-
Catalyst Pharmaceutical Partners Set to Join Russell Microcap(R) Index
6/25/2008
-
Catalyst Pharmaceutical Partners Files Form S-3 Shelf Registration Statement
6/3/2008
-
Catalyst Pharmaceutical Partners Names Director
3/5/2008
-
Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial
1/25/2008
-
Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
12/7/2007
-
Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
11/15/2007
-
Catalyst Pharmaceutical Partners to Present at The Roth Capital Partners 2007 New York Conference
8/29/2007